Table 1.
Characteristics of participants1 in relation to IDF-defined metabolic syndrome, the HUNT 2 study
| Men | Women | |||
| No metabolic syndrome | Metabolic syndrome | No metabolic syndrome | Metabolic syndrome | |
| N (%) | 3622 (71.1) | 1479 (29.0) | 3558 (69.7) | 1547 (30.3) |
| Age, y | 45.8 ± 16.6 | 55.0 ± 16.3 | 44.8 ± 16.1 | 60.2 ± 16.2 |
| Systolic BP, mm Hg | 136.9 ± 18.7 | 148.8 ± 19.9 | 130.1 ± 21.1 | 153.6 ± 24.3 |
| Diastolic BP, mm Hg | 81.2 ± 11.7 | 88.8 ± 11.7 | 77.1 ± 11.2 | 86.7 ± 12.9 |
| Waist circumference, cm | 88.2 ± 7.9 | 101.9 ± 7.3 | 77.4 ± 9.7 | 92.9 ± 9.9 |
| HDL cholesterol, mmol/L | 1.32 ± 0.33 | 1.10 ± 0.31 | 1.59 ± 0.37 | 1.30 ± 0.36 |
| Triglycerides, mmol/L | 1.31 ± 0.91 | 2.30 ± 1.40 | 0.99 ± 0.55 | 2.02 ± 1.15 |
| Glucose, mmol/L | 5.35 ± 0.93 | 5.93 ± 1.67 | 5.18 ± 0.60 | 5.98 ± 1.52 |
| Type 2 diabetes, % | 0.8 | 3.6 | 0.2 | 6.0 |
| Antihypertensive medication, % | 6.6 | 19.4 | 5.6 | 30.2 |
| Waist/hip ratio | 0.88 ± 0.05 | 0.95 ± 0.05 | 0.78 ± 0.05 | 0.85 ± 0.06 |
| BMI, kg/m2 | 25.4 ± 3.0 | 29.8 ± 3.3 | 25.0 ± 4.1 | 30.2 ± 4.5 |
| Total cholesterol, mmol/L | 5.74 ± 1.17 | 6.25 ± 1.14 | 5.75 ± 1.29 | 6.69 ± 1.37 |
Data are numbers, means ± standard deviation, or percentages.
HUNT, the Nord-Trøndelag Health study; IDF, the International Diabetes Federation; BP, blood pressure; HDL, high-density lipoprotein; BMI, body mass index.
1Fasting ≥4 hours.